Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Lung Cancer
Interventions
DRUG

temozolomide

Trial Locations (1)

44106-5065

Ireland Cancer Center, Cleveland

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Schering-Plough

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER